NCT01721590View on ClinicalTrials.gov

Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

Tongxinluo

Tongxinluo,3 capsules/time 3times/day for 1 year

DRUG

placebo

3 capsules/time，3times/day for 1 year

Trial Locations (3)

110032

ShenZhou Hopital Of ShenYang Medical College, ShengYang

110042

The 463th Hospital Of PLA, Shenyang

Unknown

Northern Hospital, Shenyang

Sponsors

Lead Sponsor

Han Yaling
All Listed Sponsors
lead

Han Yaling

OTHER

NCT01721590 - Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease | Biotech Hunter | Biotech Hunter